REQUEST A DEMO
Total
USD $0.00
Search more companies

SynCore Biotechnology Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: SynCore Biotechnology Co., Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

SynCore Biotechnology Co., Ltd (“SynCore”) is a biopharmaceutial company focusing on creating values of new drug by R&D and integration of technology resources. SynCore was established in 2008 and cofounded by Sinphar Group and National Health Research Institute (NHRI). SynCore inherited Sinphar’s experiences which have been accumulated for more than 30 years in R&D, manufacturing, and international marketing. Such experiences enables SynCore to build up the comprehensive pipeline protfolio for new drug development to fulfill domestic and international market needs and to consolidate the future development.

Headquarters
84 Chung Shan Rd.,Chung Shan Village
Yilan County; Yilan County;

Contact Details: Purchase the SynCore Biotechnology Co., Ltd. report to view the information.

Website: http://www.syncorebio.com

Basic Information
Total Employees:
Purchase the SynCore Biotechnology Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the SynCore Biotechnology Co., Ltd. report to view the information.
Financial Auditors:
Purchase the SynCore Biotechnology Co., Ltd. report to view the information.
Incorporation Date:
June 26, 2008
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
62.09%
Purchase this report to view the information.
0.47%
Purchase this report to view the information.
0.05%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Syncore Biotechnology Europe Gmbh (Germany)
100%
Company Performance
Financial values in the chart are available after SynCore Biotechnology Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
39.24%
Total operating revenue
39.41%
Operating profit (EBIT)
42.88%
EBITDA
49.55%
Net Profit (Loss) for the Period
46.6%
Total assets
-7.08%
Total equity
65.21%
Operating Profit Margin (ROS)
362.11%
Net Profit Margin
376.93%
Return on Equity (ROE)
17.19%
Debt to Equity Ratio
-26.42%
Quick Ratio
13.38%
Cash Ratio
11.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?